Skip to main content

MAIAR: MAchine learning-based prediction of medical complications and prognosis In Aneurysmal subarachnoid hemoRrhage using multi-omic data

PI23/00351

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i en Salud
Call year 2023
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO HOSPITAL DEL MAR DE INVESTIGACIONES MEDICAS (FIMIM)
Execution centre HOSPITAL DEL MAR RESEARCH INSTITUTE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Blood DNA Methylation Analysis Reveals a Distinctive Epigenetic Signature of Vasospasm in Aneurysmal Subarachnoid Hemorrhage

  • Fernandez-Perez, Isabel|||0000-0002-9949-1393
  • Jiménez-Balado, Joan|||0000-0003-4125-9134
  • Macias Gómez, Adrià|||0000-0003-0926-681X
  • Suárez-Pérez, Antoni|||0000-0002-0832-7580
  • Vallverdú-Prats, Marta|||0000-0002-5262-817X
  • Pérez-Giraldo, Alberto
  • Viles-García, Marc
  • Peris-Subiza, Julia
  • Vidal-Notari, Sergio
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Guisado-Alonso, Daniel|||0000-0002-5799-3184
  • Esteller, M.|||0000-0003-4490-6093
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Ois, Angel|||0000-0002-1375-5950
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
Vasospasm is a potentially preventable cause of poor prognosis in patients with aneurysmal subarachnoid hemorrhage (aSAH). Epigenetics might provide insight on its molecular mechanisms. We aimed to analyze the association between differential DNA methylation (DNAm) and development of vasospasm. We conducted an epigenome-wide association study in 282 patients with aSAH admitted to our hospital. DNAm was assessed with the EPIC Illumina chip (.